D3‐creatine dilution for skeletal muscle mass measurement: historical development and current status

• Published in: Journal of cachexia, sarcopenia and muscle Vol. 13; no. 6; pp. 2595 - 2607
• Main Authors: McCarthy, Cassidy, Schoeller, Dale, Brown, Justin C., Gonzalez, M. Cristina, Varanoske, Alyssa N., Cataldi, Devon, Shepherd, John, Heymsfield, Steven B.
• Format: Journal Article
• Language: English
• Published: Heidelberg John Wiley & Sons, Inc 01.12.2022; Wiley - Society on Sarcopenia, Cachexia and Wasting Disorders; John Wiley and Sons Inc; Wiley
• Subjects: Adults; Biochemistry; Biopsy; body composition; Creatinine; Estimates; isotope dilution; Malnutrition; Methods; Musculoskeletal system; nutritional assessment; Physiology; Proteins; Review; Reviews; Urine
• ISSN: 2190-5991; 2190-6009; 2190-6009
• DOI: 10.1002/jcsm.13083

The French chemist Michel Eugène Chevreul discovered creatine in meat two centuries ago. Extensive biochemical and physiological studies of this organic molecule followed with confirmation that creatine is found within the cytoplasm and mitochondria of human skeletal muscles. Two groups of investigators exploited these relationships five decades ago by first estimating the creatine pool size in vivo with 14C and 15N labelled isotopes. Skeletal muscle mass (kg) was then calculated by dividing the creatine pool size (g) by muscle creatine concentration (g/kg) measured on a single muscle biopsy or estimated from the literature. This approach for quantifying skeletal muscle mass is generating renewed interest with the recent introduction of a practical stable isotope (creatine‐(methyl‐d3)) dilution method for estimating the creatine pool size across the full human lifespan. The need for a muscle biopsy has been eliminated by assuming a constant value for whole‐body skeletal muscle creatine concentration of 4.3 g/kg wet weight. The current single compartment model of estimating creatine pool size and skeletal muscle mass rests on four main assumptions: tracer absorption is complete; tracer is all retained; tracer is distributed solely in skeletal muscle; and skeletal muscle creatine concentration is known and constant. Three of these assumptions are false to varying degrees. Not all tracer is retained with urinary isotope losses ranging from 0% to 9%; an empirical equation requiring further validation is used to correct for spillage. Not all tracer is distributed in skeletal muscle with non‐muscle creatine sources ranging from 2% to 10% with a definitive value lacking. Lastly, skeletal muscle creatine concentration is not constant and varies between muscles (e.g. 3.89–4.62 g/kg), with diets (e.g. vegetarian and omnivore), across age groups (e.g. middle‐age, ~4.5 g/kg; old‐age, 4.0 g/kg), activity levels (e.g. athletes, ~5 g/kg) and in disease states (e.g. muscular dystrophies, <3 g/kg). Some of the variability in skeletal muscle creatine concentrations can be attributed to heterogeneity in the proportions of wet skeletal muscle as myofibres, connective tissues, and fat. These observations raise serious concerns regarding the accuracy of the deuterated‐creatine dilution method for estimating total body skeletal muscle mass as now defined by cadaver analyses of whole wet tissues and in vivo approaches such as magnetic resonance imaging. A new framework is needed in thinking about how this potentially valuable method for measuring the creatine pool size in vivo can be used in the future to study skeletal muscle biology in health and disease.